MiniSeq
The MiniSeq System delivers the quality and reliability of Illumina next-generation sequencing (NGS) technology in a powerful, accessible benchtop sequencer with a small footprint. This small, robust system turns a broad range of NGS methods into approachable, easy-to-use research tools, enabling researchers to take control of their sequencing projects. With the MiniSeq System, there is no need to wait to batch samples for sequencing on a high-throughput instrument; researchers can sequence on demand.
Features
Introduced in 2016.
2-color SBS chemistry.
Random cluster/bridge amplification.
Run time: 5-24 hrs.
Benefits
Bacterial, plasmid & viral sequencing (WGS, small genomes).
Targeted regions sequencing, amplicon sequencing: 16S & ITS.
Metagenomics, Deeplex Myc-tuberculosis sequencing, CovidSeq assay, microbial amplicon
Prep, Viral Surveillance panel (VSP), AMR enrichments (UPIP).
Respiratory pathogen detection: RVOP, RPIP (AMR enrichments).
Mitochondrial DNA sequencing.
Targeted gene expression.
Small Amliseq panels: Oncology (BRCA,
focus, Cancer HotSpot, Myeloid),
Immune response, immune repertoire,
custom DNA panel.
Human Leukocyte Antigen (HLA)
typing (CareDx).
Library Quality Control
